This is the first controlled pharmacologic study to demonstrate that treatment of obesity improved PsA disease measures
Blood tests measuring biomarkers such as p-tau217 are emerging as accurate, accessible alternatives
The investigational subcutaneous hepcidin mimetic peptide is designed to regulate iron and red blood cell production
The state-of-the-art laboratory opens at the Corewell Health Southfield Center in early 2027
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
The funding will accelerate Sinopia’s data-driven drug discovery efforts
TMS offers new hope to patients suffering from stroke, migraine, neuropathic pain, depression, and other disorders
The primary goal of the collaboration is joint research into trending and next-generation molecules
The collaboration aims to combine synthetic biology with cutting-edge detection technology to create a first-of-its-kind oral pill embedded with tumor-targeting sensors
Xeureka will receive an upfront payment from UBE and will be eligible for milestone payments tied to future research progress
The MAR-Autism Test represents more than 20 years of research at the UC Davis MIND Institute by Judy Van de Water
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
SandboxAQ will receive an upfront payment and could earn up to $200 million in milestone payments tied to preclinical, development, regulatory, and commercial achievements
The companies aim to expand treatment options for millions living with metabolic disorders
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
76 of 180 long COVID-associated genes also linked to ME
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
Alport Syndrome is caused by genetic mutations affecting type IV collagen in the kidneys, ears, and eyes
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Subscribe To Our Newsletter & Stay Updated
